Home
  >  
Section 11
  >  
Chapter 10,795

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

Knutson, K.L.; Schiffman, K.; Disis, M.L.

Journal of Clinical Investigation 107(4): 477-484

2001

ISSN/ISBN: 0021-9738
PMID: 11181647
Accession: 010794806
Download citation:  
Text
  |  
BibTeX
  |  
RIS
CD4 T-cell help is required during the generation and maintenance of effective antitumor CD8 T cell-mediated immunity. The goal of this study was to determine whether HER-2/neu-specific CD8 T-cell immunity could be elicited using HER-2/neu-derived MHC class II "helper" peptides, which contain encompassed HLA-A2-binding motifs. Nineteen HLA-A2 patients with HER-2/neu-overexpressing cancers received a vaccine preparation consisting of putative HER-2/neu helper peptides p369-384, p688-703, and p971-984. Contained within these sequences are the HLA-A2-binding motifs p369-377, p689-697, and p971-979. After vaccination, the mean peptide-specific T-cell precursor frequency to the HLA-A2 peptides increased in the majority of patients. In addition, the peptide-specific T cells were able to lyse tumors. The responses were long-lived and detectable for more than 1 year after the final vaccination in select patients. These results demonstrate that HER-2/neu MHC class II epitopes containing encompassed MHC class I epitopes are able to induce long-lasting HER-2-specific IFN-gamma-producing CD8 T cells.

PDF emailed within 1 workday: $29.90




Related References

Knutson, K.L.; Schiffman, K.; Disis, M.L. 2001: Generation of HER-2/neu CD8+ T cell immunity in cancer patients following immunization with a HER2 helper peptide vaccine Proceedings of the American Association for Cancer Research Annual Meeting 42: 699
Clerici, M.; Tacket, C.O.; Via, C.S.; Lucey, D.R.; Muluk, S.C.; Zajac, R.A.; Boswell, R.N.; Berzofsky, J.A.; Shearer, G.M. 1991: Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection European Journal of Immunology 21(6): 1345-1349
Stahlhennig, C. 1992: Die Immunisierung mit HIV-Spaltvakzine induziert eine stärkere T-Helferzellen-Immunität als die natürliche Infektion - Immunization with subunit human immunodeficiency virus vaccine generates stronger T Helper cell immunity than natural infection Aids - Forschung 7(8): 415-416
Stahl Hennig, Christiane 1992: Immunization with subunit HIV vaccine induces a stronger T helper cell immunity than natural infection AIDS-Forschung 7(8): 415-416
Migliorini, P.; Betschart, B.; Corradin, G. 1993: Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity European Journal of Immunology 23(2): 582-585
Kalli, K.R.; Block, M.S.; Kasi, P.M.; Erskine, C.L.; Hobday, T.J.; Dietz, A.; Padley, D.; Gustafson, M.P.; Shreeder, B.; Puglisi-Knutson, D.; Visscher, D.W.; Mangskau, T.K.; Wilson, G.; Knutson, K.L. 2018: Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 24(13): 3014-3025
Tenma, A.; Nakagami, H.; Tomioka, H.; Sakaguchi, M.; Ide, R.; Koriyama, H.; Hayashi, H.; Shimamura, M.; Rakugi, H.; Morishita, R. 2019: AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine Faseb Bioadvances 1(12): 760-772
Li, G.; Andreansky, S.; Helguera, G.; Sepassi, M.; Janikashvili, N.; Cantrell, J.; Lacasse, C.L.; Larmonier, N.; Penichet, M.L.; Katsanis, E. 2008: A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model Molecular Cancer Therapeutics 7(3): 721-729
Li, X.; Zhang, S.; Lei, J.; Zhu, Y.; Zhou, X.; Xiao, J.; Xiang, T. 2018: Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice International Immunopharmacology 61: 100-108
Nagata, T.; Aoshi, T.; Suzuki, M.; Uchijima, M.; Kim, Y-Hyen.; Yang, Z.; Koide, Y. 2002: Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain Infection and Immunity 70(5): 2676-2680
Miller, M.A.; Skeen, M.J.; Lavine, C.L.; Kirk Ziegler, H. 2003: IL-12-assisted immunization generates CD4+ T cell-mediated immunity to Listeria monocytogenes Cellular Immunology 222(1): 1-14
Ohtake, J.; Ohkuri, T.; Togashi, Y.; Kitamura, H.; Okuno, K.; Nishimura, T. 2014: Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine Immunology Letters 161(1): 20-30
Huang, J.; Ma, R.; Wu, C.-y. 2006: Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses Vaccine 24(23): 4905-4913
Wang, R.; Baraceros, F.; Zimmerman, D.H.; Hoffman, S.L. 2000: Protective immunity against malaria by immunization with PYSSP2 CD4+ T helper epitope conjugated to MHC class II binding ligand MHC-II beta-chain peptide 135-149 American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 331-332
Knutson, K.L.; Crosby, P.; Disis, M.L. 1999: Isolation of HER-2/neu specific T cell clones from a breast cancer patient following immunization with a HER2 peptide vaccine Proceedings of the American Association for Cancer Research Annual Meeting 40: 310-311
Prota, G.; Christensen, D.; Andersen, P.; Medaglini, D.; Ciabattini, A. 2015: Peptide-specific T helper cells identified by MHC class Ii tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation Vaccine 33(48): 6823-6830
Casares, N.; Lasarte, J.J.; de Cerio, A.L.; Sarobe, P.; Ruiz, M.; Melero, I.; Prieto, J.; Borrás-Cuesta, F. 2001: Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity European Journal of Immunology 31(6): 1780-1789
Chung, Y.; Qin, H.; Kang, C-Yuil.; Kim, S.; Kwak, L.W.; Dong, C. 2007: An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity Blood 110(6): 2013-2019
Knutson, K.L.; Schiffman, K.; Cheever, M.A.; Disis, M.L. 2002: Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(5): 1014-1018
Knutson, K.L.; Schiffman, K.; Disis, M.L. 2002: Immunization with a HER-2/neu , HLA-A2 peptide, p369-377, in cancer patients results in short-lived peptide-specific immunity Proceedings of the American Association for Cancer Research Annual Meeting 43: 562